GNH USA

Europe — EMA

Memantina Aurobindo

GNH USA supplies Memantina Aurobindo (Memantine Hydrochloride), a NMDA receptor antagonist for Alzheimer's disease. Request a quote for global supply.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine Hydrochloride, the active ingredient in Memantina Aurobindo, is a NMDA receptor antagonist presented as an oral tablet for oral administration. It is indicated for the symptomatic treatment of moderate to severe Alzheimer’s disease, helping to improve cognition and daily functioning in adult patients.

GNH USA supplies Memantina Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards and through ensuring consistent quality and traceability.

What is Memantine Hydrochloride used for?

Memantine Hydrochloride is an NMDA receptor antagonist used in the management of neurodegenerative disorders.

Alzheimer's disease: improves cognitive function and daily activities in patients with moderate to severe disease.

What are the side effects of Memantine Hydrochloride?

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Somnolence

Serious or Rare Side Effects: - Seizures - Cardiac arrhythmias - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction - Acute hypertension

What precautions apply to Memantine Hydrochloride?

Memantine Hydrochloride requires careful consideration in several clinical situations. - Renal impairment: dose adjustment may be needed in patients with reduced kidney function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - History of seizures: use with caution as the drug may lower seizure threshold. - Elderly patients: start at low dose and titrate slowly to reduce adverse events. - Concomitant NMDA agonists: avoid combined use due to potential antagonistic effects. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

What does Memantine Hydrochloride interact with?

Memantine Hydrochloride can interact with several medicines that affect the NMDA pathway or central nervous system. Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity. - Dextromethorphan: combined NMDA blockade can enhance central side effects. - Ketamine: concurrent use may intensify dissociative symptoms. - Other NMDA antagonists: risk of excessive inhibition of glutamatergic transmission. - High‑dose zinc supplements: may reduce memantine absorption.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal dysfunction. - Antihypertensives: monitor blood pressure as memantine can cause hypertension. - Anticholinergic agents: may worsen cognitive impairment. - SSRIs: observe for increased central nervous system effects. - Antiepileptic drugs: monitor seizure control closely.

Frequently asked questions

What is Memantina Aurobindo used for?+
Memantina Aurobindo contains memantine hydrochloride, which is prescribed for the symptomatic treatment of moderate to severe Alzheimer’s disease. It helps to improve cognition, memory, and daily functional abilities in adult patients by modulating glutamatergic activity in the brain.
How does memantine hydrochloride work?+
Memantine hydrochloride works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium influx through the receptor‑associated ion channel, it reduces excitotoxic neuronal damage that contributes to cognitive decline in Alzheimer’s disease.
What is the usual dose of Memantina Aurobindo?+
The dosage of Memantina Aurobindo is determined by the prescribing clinician based on the patient’s condition, age, renal function, and other clinical factors. The prescriber will set the appropriate dose and titration schedule according to current medical guidelines.
Is Memantina Aurobindo safe during pregnancy or breastfeeding?+
Safety data for memantine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Memantina Aurobindo from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.
How does Memantina Aurobindo compare with other Alzheimer’s drugs?+
Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents such as donepezil, rivastigmine, and galantamine are cholinesterase inhibitors. Memantine is typically used in moderate to severe disease and may be combined with a cholinesterase inhibitor for additive benefit, while the others are often started earlier in the disease course.
What are the storage and handling requirements for Memantina Aurobindo?+
Memantina Aurobindo should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Memantina Aurobindo administered?+
The medication is taken orally, usually once daily, with or without food as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with Memantina Aurobindo?+
Serious adverse events, although rare, include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and acute hypertension. Patients should be monitored for any new or worsening symptoms and seek medical attention promptly if serious reactions occur.
Who should not use Memantina Aurobindo?+
Memantina Aurobindo is contraindicated in patients with known hypersensitivity to memantine or any of the excipients. Caution is advised for individuals with severe renal or hepatic impairment, a history of seizures, or those taking other NMDA antagonists, as these conditions may increase the risk of adverse effects.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
Aurobindo Pharma (Italia) S.R.L.
Origin
EU

Related products